Most Recent
Hollywood movie giant Warner Bros has lost its opposition to an Australian winemaker's proposed 'Beetlejuice' trade mark.
The High Court won't hear Bayer's appeal of an invalidity finding over patents for blood thinner Xarelto, despite the company's claim the decision has "profound" consequences for drug R&D.
Fonterra, which has taken cheese maker Bega to court to resolve a dispute over the dairy company's plans to exit the Australian market, is resisting a bid for discovery in the case.
The IP holder of the The Hobbit and Lord of the Rings franchises has lost its challenge to registration of a trade mark by vegan burger chain Lord of the Fries.
A delegate has ordered the removal of Macquarie's 'Macbank' trade mark, finding no evidence of use in the course of trade despite the moniker being widely used to refer to the bank colloquially.
Discount grocery giant Aldi has lodged an appeal after a court found its Mamia Baby Puffs copied the look of rival Little Bellies baby snacks.
Otsuka Pharmaceuticals is challenging a decision revoking its patent for an injectable version of antipsychotic drug Abilify.
Pharmaceutical giant Lundbeck has resolved its battle with Novartis unit Sandoz over top-selling drug Lexapro, a battle that has raged for years and across multiple courts.
The trustee for iconic Aussie pop band Men at Work wants a court's guidance on who it should be making royalty payments to, after guitarist Ron Strykert contested an agreement he signed.